4月2日 - ** Inovio Pharmaceuticals INO.O股价盘前下跌17%至1.45美元左右
** 这家生物技术公司称，它已暂停与奥本海默公司的场内股票发行计划
** 补充说，该计划允许公司直接向市场出售新发行的股票
** 在提交新的招股说明书之前不会出售更多股票 - INO
** 公司补充说，与奥本海默的销售协议仍然有效，但没有新的发行计划
** Inovio 称已根据该计划售出约 130 万股股票，在扣除费用前共筹集约 320 万美元。
** 文件由首席财务官彼得-基斯（Peter Kies）签署
** 截至上次收盘，股价今年以来持平
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.